Zuellig Pharma
Mega Lifesciences

MSN LABORATORIES PRIVATE LIMITED

Featured products of MSN Laboratories
erlotinib
Packing/Price
3 × 10's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EB02 - erlotinib : Belongs to the class of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
imatinib
Packing/Price
6 × 10's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EA01 - imatinib : Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.
imatinib
Packing/Price
3 × 10's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EA01 - imatinib : Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.
Distributed by Zuellig Pharma
erlotinib
Packing/Price
3 × 10's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EB02 - erlotinib : Belongs to the class of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
imatinib
Packing/Price
6 × 10's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EA01 - imatinib : Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.
imatinib
Packing/Price
3 × 10's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EA01 - imatinib : Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.
Marketed by Mega Lifesciences
erlotinib
Packing/Price
3 × 10's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EB02 - erlotinib : Belongs to the class of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
imatinib
Packing/Price
6 × 10's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EA01 - imatinib : Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.
imatinib
Packing/Price
3 × 10's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EA01 - imatinib : Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.